Search

everythinglearnresearchcommunity

for

Search:↓

The book concludes that despite progress, cancer drug treatments have not met the expectations set in the 1960s and 1970s.

Cooling the scalp below 22°C before and during chemotherapy can help prevent hair loss.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Green tea extract helps prevent cell death and supports cell survival in hair cells exposed to a chemotherapy drug.

Most pediatric cancer patients at Muhimbili National Hospital in Tanzania experienced side effects from chemotherapy, with nausea, hair loss, and low white blood cell count being the most common.

Medical treatments like chemotherapy and radiotherapy can harm sperm production, so freezing sperm before treatment is important for men who want children later.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

The document is a detailed guide on skin conditions and treatments for dermatologists.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

A man experienced hair loss from radiotherapy, which can be temporary or permanent depending on radiation dose, with potential treatments available.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

Nano-sized plant-based chemicals could improve cervical cancer treatment by being more effective and causing fewer side effects than current methods.

Interleukin-2 treatment improved hair growth, sexual function, and reduced fungal infection in a patient with thymoma-related symptoms.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.